Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.52 - $3.39 $51,376 - $114,582
33,800 Added 81.64%
75,200 $115,000
Q2 2022

Aug 15, 2022

SELL
$1.6 - $5.07 $640,000 - $2.03 Million
-400,000 Reduced 90.62%
41,400 $1,000
Q4 2021

Feb 14, 2022

BUY
$5.0 - $14.85 $2.21 Million - $6.55 Million
441,400 New
441,400 $238,000
Q2 2021

Aug 16, 2021

SELL
$10.82 - $19.37 $3.84 Million - $6.88 Million
-355,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$7.02 - $22.62 $2.49 Million - $8.03 Million
355,000 New
355,000 $364,000

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.